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ABSTRACT 
Background and purpose: Acid has long been thought to play an important role in the pain 
process. Animal study showed that repeated acid stimulation induced central sensitization. 
The purpose of the study is to investigate muscle pain and hyperalgesia evoked by 
intramuscular infusion of saline at different pH levels, and to compare the effect of a single 
versus repeated acid infusions.  
Methods: Twenty healthy subjects received infusions of buffered saline (pH 5.0, 6.0, and 
7.4) into the brachioradialis muscle in a randomized order. Twelve of the subjects received 
repeated infusions. The subjects rated the pain intensity on visual analogue scale (VAS). 
Thermal pain sensitivity, and pressure pain threshold (PPT) were assessed in both arm before, 
during, immediately after, one hour after, and one day after the infusion. A McGill Pain 
Questionnaire and pain mapping were completed after each infusion.  
Results: The pH 5 solution caused significantly higher pain and larger areas than pH 6.0 or 
7.4. The local PPTs were significantly decreased (hyperalgesia) during and immediately after 
infusion of all three solutions. No significant differences were detected between the first and 
second infusion.  
Conclusions: The intensity of acid-induced muscle pain is pH-dependent. All three solutions 
induced pressure hyperalgesia at the infusion site. Repeated infusions did not induce 
increased pain or prolonged hyperalgesia as compared with a single injection. Human 
intramuscular acidic saline infusion could not produce chronic pain model. 
Implications: The acid-induced pain model may reflect the early stage responses to tissue 
injury of clinical conditions. Repeated intramuscular acidic saline injection model of 
prolonged hyperalgesia in rodents could not be translated into a human for modelling chronic 
musculoskeletal pain.  
Key words: Acid-induced pain; Hyperalgesia; Muscle pain; Experimental pain; Gender 
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1. Introduction 
Tissue acidosis has been observed as a regular phenomenon following inflammation, 
ischemia, arthritis, cancer, hematomas, and exercise 
1, 2, 3
. Local tissue pH has been found to 
drop to 5.4 in purulent exudates, 4.7 in fracture-related hematomas, 5.0-4.0 in bone cancer, 
and 6.0 in patients with occlusive arterial diseases in the leg 
3
. Considering the painful nature 
of all the conditions above, the high proton concentration might be a significant contributor to 
the associated pain 
1, 4
. Previous studies also suggest that a strong reciprocal pain potentiating 
interaction exists between acidic pH and several inflammatory mediators and 
neurotransmitters, with low pH playing the dominant role 
5, 6, 7
. The acid-sensing ion channels 
(ASICs) play an important role in the activation of nociceptors by low pH and thus may serve 
as potential targets for analgesic drug developing 
3, 4, 6, 8, 9, 10
.  
Human and animal studies have shown that acid can induce both transient and sustained 
pain 
3, 4, 11
. An acid-induced pain model in rats has been proven to be safe and without 
significant tissue damage by histological biopsy compared with other inflammation or 
tumour-induced pain models in rodents 
11
. Using acid to produce pain in human skin and 
muscle has also proven safe 
12, 13, 14
. Primary mechanical hyperalgesia was reported to be 
observed following the acid stimulation. In spite of the different methods adopted, the 
intensity of the acid-induced pain is pH-dependent 
3, 7, 13, 14
. A previous study including 
intramuscular acidic stimulation reported that women experienced higher referred pain and 
exhibited a stronger correlation between local and referred pain than men 
13
. 
Animal studies have reported that repeated intramuscular acidic stimulations induced 
spinal hyperexcitability with contralaterally spreading hyperalgesia 
8, 11, 15, 16.  Local 
anaesthetics applied to the muscle previously injected with acidic saline could not inhibit the 
acid-induced contralateral spreading of hyperalgesia 
11
 indicating a central origin of the 
phenomenon. However, spreading of pain has not been found after repeated acid injection 
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into the masseter muscle in neither human 
12
 nor animal studies 
17
. Since the results from 
human research within this field are limited, further studies should be conducted to elucidate 
the possible central mechanism of acid-induced muscle pain. 
The aims of this human study were to investigate: 1) whether acid-induced muscle pain 
and 2) pressure hyperalgesia were pH dependent; 3) if spreading sensitization could be 
evoked by repeated versus single injection of acid stimulation; and 4) if there were gender 
differences in any of the parameters. 
 
2. Methods 
2.1 Subjects 
Twenty healthy subjects (7 women, 24.3±3.1 years) participated in a three-session study with 
a single infusion in each session. Further, 12 of the 20 subjects (4 women, 24.1±2.8 years) 
participated in sessions with repeated infusions. None of the subjects had a history of pain or 
injuries or medical conditions that could interfere with normal somatosensory functioning. 
Women in the menstrual period were avoided. The study was approved by the local ethics 
committee (N 2011-0081) and conducted in accordance with the Declaration of Helsinki. All 
subjects gave written informed consent. 
 
2.2 Experimental Protocol 
The subjects participated in three sessions; each with a single infusion of buffered saline with 
one of three different pH levels (pH 5.0, 6.0 and 7.4). The infusions were conducted in 
random order and with a one-week interval between sessions. Further, 12 subjects received 
repeated infusions of either pH 5.0 or pH 7.4 solution with a one-day interval between 
infusions. In each session, neutral phosphate buffered saline (10 ml) was infused into the 
brachioradialis muscle over 20 min using a computer-controlled infusion pump.  
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Cold pain threshold (CPT), heat pain threshold (HPT), mechanical pain sensitivity 
(MPS), and pressure pain threshold (PPT) were assessed before, during, after, one hour after, 
and one day after the infusion. The pain intensity was rated by means of an electronic visual 
analogue scale (VAS). A McGill Pain Questionnaire and a pain map were completed after 
each infusion.   
 
2.3 Acidic Infusions and Pain Assessment 
The pH adjusted phosphate buffered saline (10 mL, Hospital Pharmacy of Aalborg University 
Hospital, Aalborg, Denmark) was randomly infused into the left brachioradialis muscle (2 cm 
from the superior border of cubital fossa) in a double-blinded manner with respect to the pH 
level. The infusion site was cleaned with alcohol and dried prior to the needle insertion. The 
needle (27 G, 19 mm, BD Microlance 3, Becton Dickinson, Ireland) was inserted into middle 
part of the brachioradialis muscle with a depth of 15 mm. The inserted needle was fixed to 
the skin using surgical tape and sterile cotton. A tube (200 cm, 1.5 ml, G30303M, Care 
Fusion, Switzerland) was connected to the needle from the syringe. The sterile buffers were 
infused at a constant rate of 30 ml/h for 20 minutes using a computer-controlled infusion 
pump (Asena CC MK-III, Alaris medical systems, USA). The needle and tube were removed 
immediately after completion of the infusion.  
The subjects rated the induced pain intensity on an electronic VAS on which "0 cm" 
indicated "no pain" and "10 cm" represented "most pain imaginable". The VAS signal was 
sampled every 2 seconds from the beginning of the infusion until the pain intensity had 
returned to zero. The maximal pain (VAS peak) and the area under the curve (VAS area) were 
calculated. After the infusion, the subjects were asked to draw the pain areas on an arm 
drawing describe the quality of the pain on the McGill Pain Questionnaire (MPQ).  
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2.4 Assessment Sites 
Two sites in the infusion side and two sites in the contralateral side were assessed (Fig. 1). 
CPT, HPT MPT, and PPT were assessed 1 cm from the infusion site (T2). All sensory 
assessments were also conducted at the infusion site (T1) at the same time points except 
during infusion. Further, the assessments were performed on the contralateral arm at the 
corresponding sites as controls (C2 and C1).  
 
2.5 Cutaneous Thermal Pain Sensitivity  
Cold pain threshold (CPT) and heat pain threshold (HPT) were measured (TSA 2001 II 
(CHEPS, Medoc, Israel) at T1 and C1 sites. The contact area of the thermode was 9 cm
2
. The 
baseline temperature was 32 C° (centre of neutral range). The method of limits was used by 
applying ramp stimuli at a velocity of 1 C°/s. The cut-off temperatures were 0 C° and 55 C°. 
The volunteers were asked to press a button when the respective thermal sensations were 
perceived. The mean threshold temperature of three consecutive measurements was 
calculated.  
 
2.6 Cutaneous Mechanical Pain Sensitivity  
The cutaneous sensitivity was assessed using weight-calibrated pins (128 mN, custom made 
Aalborg University) at all assessment sites. The subjects rated the cutaneous mechanical pain 
sensitivity (MPS) on a 0-5-10 Numeric Rating Scale (NRS) on which "0" represented “no 
sensation", "5" represented "pain threshold", and "10" presented "worst pain imaginable". 
The mean of the three measurements was used in the statistical analysis. 
 
2.7 Pressure Pain Sensitivity 
A hand-held pressure algometer (Somedic AB, Sweden) was used to assess the PPTs. The 
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pressure was applied to all assessment sites at a constant rate of 30 kPa/s through a 1 cm
2
 
probe. The subjects were instructed to push a button immediately when they felt the pressure 
turning into pain. The PPTs were measured twice at each site. The interval between the two 
PPT trials was at least 40 sec and the mean of the two measurements was used in the 
statistical analysis. 
 
2.9 Statistics 
The normal distribution was checked for all data. The necessary logarithmic transformation 
was performed 
18
. QST data were then analysed using a 3-way repeated measure analysis of 
variance (ANOVA) with gender as between-subject factor and testing site (T1, T2, C1, C2), 
pH levels (pH 5.0, 6.0, 7.4) and time (baseline, during, after, one hour after, and one day 
after) as within-subject factors. The VAS scores and pain areas of the different pH levels and 
of the single and repeated infusions were analysed by 2-way (pH level and gender) repeated 
measure of ANOVA. A Bonferroni test was employed for post-hoc comparisons in case of 
significant ANOVAs. All statistical calculations were performed using the Statistical Package 
for Social Sciences version 20 (SPSS, IBM). The significance level was set at P<0.05. The 
data are presented as mean and standard error of the mean (SEM).  
 
3. Results 
3.1 Acidic-evoked Pain  
The VAS profiles of the three infusions with different pH levels are shown in Fig. 2A. 
Significant differences were detected in VAS peak (ANOVA: P < 0.023, Fig. 2B) and VAS 
area (ANOVA: P < 0.012, Fig. 2C). The infusion of the pH 5.0 solution caused higher VAS 
scores (Peak 4.65) than the pH 6.0 solution (Peak 3.37) (P= 0.015) and the 7.4 solution (1.68) 
(P = 0.001). In addition, the pH 7.4 solution caused the lowest VAS scores compared with the 
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pH 6.0 solution (P= 0.016).  
The pain areas following the three different solutions are illustrated in Fig. 3. Infusion 
of the pH 5.0 solution evoked a larger area than infusion of pH 6.0 (P =0.036) and 7.4 (P 
=0.004), whereas the pH 7.4 solution evoked the smallest area compared with pH 6.0 and pH 
5.0 solution (P< 0.021).  
No gender differences were detected in VAS peak, VAS area, or drawing areas (P > 
0.092). 
 
3.2 Cutaneous Thermal and Mechanical Pain Sensitivity  
The ANOVA of the CPT, HPT, or MPS among the different solutions at any of the tested sites 
were not significant (ANOVA: P > 0.073). Likewise, no significant change was detected 
before, during, immediately after, one hour after, and one day after the infusion (ANOVA: P 
> 0.103,) or between gender (ANOVA: P > 0.087, data not presented).     
 
3.3 Pressure Pain Sensitivity  
The ANOVA demonstrated that the PPTs were different over time (ANOVA: P < 0.017) but 
not between solutions pH levels (P > 0.092). Compared with baseline, relative PPTs 
decreased immediately after, 1 hour after, and 1 day after the infusion at T1 (p<0.017) and 
during infusion at the T2 site (p<0.030) (Fig. 4AB). No significant difference was detected in 
the contralateral sites (ANOVA: P > 0.105; Fig. 4CD) and no gender difference was found 
(ANOVA: P > 0.087).   
 
3.4 Repeated Infusions 
Eight out of 12 subjects received repeated infusion of pH 5.0 solution, and 4 of them received 
repeated infusion of pH 7.4 solution No significant difference in VAS scores was detected 
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between the two repeated sessions for neither pH 5.0 nor pH 7.4 (P > 0.195) (Fig. 5A). No 
difference was detected in CPT, HPT, MPS or PPT between the two repeated sessions for 
either pH 5.0 or pH 7.4 (ANOVA: P > 0.106, data not presented). Normalized PPT values 
after the 1
st
 and 2
nd
 infusion of pH 5.0 is shown in Fig. 5B. 
 
4. Discussion 
The intensity of the acid-induced muscle pain was pH dependent whereas the deep tissue 
pressure hyperalgesia was not pH dependent. Repeated acid stimulation did not induce more 
pain or prolonged pressure hyperalgesia as compared with a single injection. No gender 
differences were found. 
 
4.1 Acid-induced Muscle Pain  
In the present study, the single infusions of the pH solution into the human forearm muscle 
produced significantly higher pain intensities than the neutral buffer (pH 7.4) and the pH 6.0 
buffer infusions, which is consistent with previous studies on acidic muscle pain models 
13, 19,
. 
The study is the first to use infusion of buffered saline with different pH levels into the same 
group of human muscles. The results provide clear evidence that the acid-evoked pain was 
pH dependent. The thin myelinated Group III and unmyelinated Group IV nerve fibres in 
muscle are responsible for transmitting muscular nociceptive information and their endings 
are sensitive to inflammatory mediators including low pH stimulation 20, 21. The decrease in 
tissue pH following muscle ischemia is believed to activate ASICs in muscle nociceptors, 
thus contributing to e.g. ischaemic muscle pain 
8, 19, 22, 23
. Clinically it is known that local 
anaesthetics with pH levels as low as 5 occasionally produce transient pain upon injection 
24, 
25
. Thus acidic infusion could be used as a muscle pain model in both animal and human 
studies.  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
11 
 
 
4.2 Factors affecting the pain evoked by acid infusions 
Factors such as infusion volume and muscle size could affect acid-evoked pain intensity. In 
the present study, a total of 10 ml of buffered acid saline was infused into the brachioradialis 
muscle at a rate of 30ml/h. The average peak pain intensity of the evoked pain was 4.65 cm 
for the pH 5.0, 3.37 cm for the pH 6.0, and 1.68 pH 7.4 solution (Fig. 2). In previous animal 
and human studies, different volumes were used to induce pain. In studies examining male 
rats, acidic saline was injected in volumes of 20 µL into the rat masseter 
26 
and rat 
gastrocnemius muscle 
8,
 which successfully evoked pain and hyperalgesia. However, in 
human studies with injection of 0.5 ml unbuffered acid saline, approximately 3% of the total 
volume of the human masseter muscle which was comparable to the relative injection volume 
used in the rats, no significant pain was induced when compared with neutral saline injections 
12
. Infusion of five times the volume (2.5 mL) of unbuffered acidic saline into the masseter 
muscle of human subjects induced pain levels similar to the results of single injection (0.5 ml) 
in previous study 
27
.  Thus, the results of the previous human studies did not provide 
evidence that the injection/infusion volume had a major impact on the acid-induced pain 
intensity. It seems other factors, such as infusion rate, and using buffered saline may play 
more important role in the acid-evoked pain intensity. However, the injection or infusion 
volume should be considered according to the muscle volume when using an acid infusion as 
pain model. 
The infusion rate may play an important role in the acid-evoked pain. A previous study 
on acid-induced human skin pain indicated that raising the infusion rate leads to increasing 
pain by lowering the local pH more effectively and by increasing the tissue volume in which 
the proton concentration exceeds the threshold to excite nociceptors 
28
. Infusion of isotonic 
pH 5.2 phosphate buffer into the flexor carpi radialis muscle produced pain correlated with 
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the flow rate of the infusion 
19
. In a recent human study, acid saline (pH 3.3) was infused into 
the masseter muscle with a slow infusion rate of 15ml/h. The infusion evoked only mild pain 
and no mechanical allodynia or increased release of algesic substances assessed by 
microdialysis were detected 
27
. In our previous study, acid saline (pH 5.2) was infused into 
the anterior tibialis muscle and the pain level was higher and PPTs were lower following an 
infusion rate of 40 mL/h compared to the infusion rate of 20 ml/h 
13
. In the present study, the 
infusion rate of 30 mL/h was selected since the expected pain intensity was evoked by both 
pH 5.0 and pH 6.0 buffered saline during the pilot experiments when the different infusion 
rates of 10ml, 20 ml, 30ml, and 40 ml were tested. 
In addition, using buffered saline instead of unbuffered saline might be the necessary to 
evoke pain. Previous human studies have suggested that acid-induced muscle pain may be 
more effectively produced by infusion of low pH (~5) phosphate buffers 
13, 28
 than by 
injections of unbuffered acidic saline 
12, 27
. Recent human studies did not evoke the expected 
pain by means of unbuffered acid saline with pH 3.3 
12, 27
. This difference is possibly due to 
the ability of the muscle tissue to rapidly buffer pH changes after injections of acidic 
solutions. Compared with a buffered saline solution, an unbuffered saline solution could 
physiologically regain pH level more quickly because of the buffering capacity of the muscle 
tissue. Since ACIC3 channels generate sustained currents as long as the pH is acidic 
29
, the 
longer the pH in the muscle remains acidic and the longer the ASIC3 channels will be 
activated.  
 
4.3 Mechanical Hyperalgesia 
In the present healthy human study, PPT values at the infusion site (T1) and around the 
infused site (T2) were significantly decreased during the acidic infusion compared with 
baseline. However, no mechanical hyperalgesia was observed in the contralateral side 
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indicating that the acidic infusion caused local sensitisation without central mechanisms 
being involved. Further, no significant difference was detected in the three different pH 
solutions indicating that the local mechanical hyperalgesia was not pH-dependent but most 
likely a volume effect. Similar mechanical hyperalgesia was observed in the experimental 
muscle pain model conducted by injecting acidic buffer into the anterior tibialis muscle 
13
. In 
contrast, in a recent human study acid-infusion into the masseter muscle did not evoke 
mechanical hyperalgesia in either the local or contralateral side 
27
. It seems that only localised 
pain and short period local hyperalgesia were observed after infusion of acidic buffer in 
human studies. 
 
4.4 Gender Differences 
No sex-related differences in pain intensity, pain areas, or induced local pressure hyperalgesia 
were observed among the three different infusions in the present study. A previous study of 
intramuscular acidic stimulation reported that women experienced higher referred pain and 
exhibited a stronger correlation between local and referred pain than men 
13
. In rats, 
expression of ASIC3 receptors is greater in masseter muscle sensory afferent fibers in females 
compared with males 
30
.  It is unclear if a similar difference in ASIC channel expression 
occurs in humans or if the expression of ASIC channels by sensory afferent fibers varies 
depending on the muscle assessed. The present study only included a relatively small study 
sample. The non-significant findings may have resulted from inadequate statistical power. 
Future studies in humans may help to address whether there indeed sex-related differences in 
acid induced muscle pain.   
  
4.5 Effect of Repeated Acid Infusions 
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In animal studies, repeated intramuscular injections of acidic saline produced a prolonged 
bilateral mechanical hyperalgesia lasting up to 30 days 
11
 providing the first insight into the 
molecular mechanisms underlying the development of chronic muscle hyperalgesia 
8
. 
However, in the present human study, contralateral spreading of pain and hyperalgesia was 
not observed following repeated infusions of acidic saline. In line, repeated infusion of 
unbuffered acidic saline into human masseter muscle did not evoke any mechanical 
hyperalgesia in either the local or the contralateral side 
12, 27
. Repeated infusions into the 
tibialis muscle induced short-lasting (20 minutes) local hyperalgesia without involving the 
contralateral side 
13
. It is not clear why the repeated acidic infusion in humans did not 
reproduce any long-lasting and widespread hyperalgesia similar to those in animals. It should 
be noted that conflicting results were also found in a previous animal study where the 
mechanical allodynia could not be detected after two repeated injections of acidic saline into 
the masseter muscle 
17
. The modality differences between acidic saline, buffered or 
unbuffered, flow rate, infusion volume, intervals between repeated infusions, different 
muscles, trigeminal region vs spinal region, and evoked pain intensity are likely to contribute 
to the controversial results. Another explanation might be the difference in the total amount 
of acid stimulation between the animal and human studies as a larger part of the muscle was 
actually stimulated in the animals; whereas only a small part of the muscle was affected in 
humans.  Again, the relatively smaller sample size may also contribute to the negative 
result.  
 
5.  Conclusions 
Infusions into the brachioradialis muscle induced pain that was pH-dependent and 
mechanical hyperalgesia that was pH independent. However, repeated intramuscular acidic 
saline injection model of prolonged hyperalgesia in rodents could not be translated into a 
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human for modelling chronic musculoskeletal pain.  
 
6. Implications 
The acid-induced pain model may reflect the early stage responses to tissue injury of clinical 
conditions. It was not possible to use this human intramuscular acidic saline infusion model 
to produce the type of prolonged local and widespread hyperalgesia that has previously been 
demonstrated to occur in animal models.  
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Figure legends 
Fig. 1. Infusion Sites and Testing Sites  
T1: infusion site on the left brachioradialis muscle; T2: local testing site, 1 cm from infusion 
site. C1 and C2: testing sites on the contralateral brachioradialis muscle   
 
Fig. 2. Visual Analogue Scale (VAS) Profile and Pain Area Under the Curve 
Mean VAS scores after pH 5.0 (blue), pH 6.0 (red), or pH 7.4 (green) infusion of acidic 
buffered saline into the left brachioradialis muscle in healthy humans (Mean ± Standard Error, 
N=20). * indicates significant difference (P < 0.05).   
 
Fig. 3. Pain Drawing Area 
The pain distribution after pH 5.0, pH 6.0, or pH 7.4 infusion of acidic buffered saline into 
the left brachioradialis muscle in healthy humans (N=20). Blue and red lines represent men 
and women, respectively. 
 
Fig. 4. Pressure Pain Threshold 
Mean (± standard error of the mean, N=20) pressure pain thresholds relative (%) to baseline 
measures on the infused site T1 (A), local site T2 (B) and contralateral side C1 (C), C2 (D) 
by the infusion of pH 5.0 (blue), pH 6.0 (red), or pH 7.4 (green) buffered saline into the left 
brachioradialis muscle in healthy humans. * indicates significant difference (P < 0.05) 
compared with baseline. 
 
Fig. 5. VAS scores and PPT Changes after Repeated Infusion 
A: Mean VAS scores of the first (blue solid line) and second (blue dotted line) infusion of pH 
5.0 acidic saline (N=8) and the first (green solid line) and second (green dotted line) infusion 
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of pH 7.4 neutral phosphate buffered saline (N=4) into the left brachioradialis muscle in 
healthy humans (N=12). B: Means of % changes (relative changes to the baseline of the 
respective days) of pressure pain threshold from the baseline at the T2 testing site after the 
first (blue) and second (black) infusion of pH 5.0 acidic saline into the left brachioradialis 
muscle in healthy humans. The relative changes of PPTs were significantly lower during 
infusion of pH 5.0 acidic saline, but no significant difference was detected between two 
repeated sessions. 
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ABSTRACT 
Background and purpose: Acid has long been thought to play an important role in the pain 
process. Animal study showed that repeated acid stimulation induced central sensitization. 
The purpose of the study is to investigate muscle pain and hyperalgesia evoked by 
intramuscular infusion of saline at different pH levels, and to compare the effect of a single 
versus repeated acid infusions.  
Methods: Twenty healthy subjects received infusions of buffered saline (pH 5.0, 6.0, and 
7.4) into the brachioradialis muscle in a randomized order. Twelve of the subjects received 
repeated infusions. The subjects rated the pain intensity on visual analogue scale (VAS). 
Thermal pain sensitivity, and pressure pain threshold (PPT) were assessed in both arm before, 
during, immediately after, one hour after, and one day after the infusion. A McGill Pain 
Questionnaire and pain mapping were completed after each infusion.  
Results: The pH 5 solution caused significantly higher pain and larger areas than pH 6.0 or 
7.4. The local PPTs were significantly decreased (hyperalgesia) during and immediately after 
infusion of all three solutions. No significant differences were detected between the first and 
second infusion.  
Conclusions: The intensity of acid-induced muscle pain is pH-dependent. All three solutions 
induced pressure hyperalgesia at the infusion site. Repeated infusions did not induce 
increased pain or prolonged hyperalgesia as compared with a single injection. Human 
intramuscular acidic saline infusion could not produce chronic pain model. 
Implications: The acid-induced pain model may reflect the early stage responses to tissue 
injury of clinical conditions. Repeated intramuscular acidic saline injection model of 
prolonged hyperalgesia in rodents could not be translated into a human for modelling chronic 
musculoskeletal pain.  
Key words: Acid-induced pain; Hyperalgesia; Muscle pain; Experimental pain; Gender 
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1. Introduction 
Tissue acidosis has been observed as a regular phenomenon following inflammation, 
ischemia, arthritis, cancer, hematomas, and exercise 
1, 2, 3
. Local tissue pH has been found to 
drop to 5.4 in purulent exudates, 4.7 in fracture-related hematomas, 5.0-4.0 in bone cancer, 
and 6.0 in patients with occlusive arterial diseases in the leg 
3
. Considering the painful nature 
of all the conditions above, the high proton concentration might be a significant contributor to 
the associated pain 
1, 4
. Previous studies also suggest that a strong reciprocal pain potentiating 
interaction exists between acidic pH and several inflammatory mediators and 
neurotransmitters, with low pH playing the dominant role 
5, 6, 7
. The acid-sensing ion channels 
(ASICs) play an important role in the activation of nociceptors by low pH and thus may serve 
as potential targets for analgesic drug developing 
3, 4, 6, 8, 9, 10
.  
Human and animal studies have shown that acid can induce both transient and sustained 
pain 
3, 4, 11
. An acid-induced pain model in rats has been proven to be safe and without 
significant tissue damage by histological biopsy compared with other inflammation or 
tumour-induced pain models in rodents 
11
. Using acid to produce pain in human skin and 
muscle has also proven safe 
12, 13, 14
. Primary mechanical hyperalgesia was reported to be 
observed following the acid stimulation. In spite of the different methods adopted, the 
intensity of the acid-induced pain is pH-dependent 
3, 7, 13, 14
. A previous study including 
intramuscular acidic stimulation reported that women experienced higher referred pain and 
exhibited a stronger correlation between local and referred pain than men 
13
. 
Animal studies have reported that repeated intramuscular acidic stimulations induced 
spinal hyperexcitability with contralaterally spreading hyperalgesia 
8, 11, 15, 16.  Local 
anaesthetics applied to the muscle previously injected with acidic saline could not inhibit the 
acid-induced contralateral spreading of hyperalgesia 
11
 indicating a central origin of the 
phenomenon. However, spreading of pain has not been found after repeated acid injection 
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into the masseter muscle in neither human 
12
 nor animal studies 
17
. Since the results from 
human research within this field are limited, further studies should be conducted to elucidate 
the possible central mechanism of acid-induced muscle pain. 
The aims of this human study were to investigate: 1) whether acid-induced muscle pain 
and 2) pressure hyperalgesia were pH dependent; 3) if spreading sensitization could be 
evoked by repeated versus single injection of acid stimulation; and 4) if there were gender 
differences in any of the parameters. 
 
2. Methods 
2.1 Subjects 
Twenty healthy subjects (7 women, 24.3±3.1 years) participated in a three-session study with 
a single infusion in each session. Further, 12 of the 20 subjects (4 women, 24.1±2.8 years) 
participated in sessions with repeated infusions. None of the subjects had a history of pain or 
injuries or medical conditions that could interfere with normal somatosensory functioning. 
Women in the menstrual period were avoided. The study was approved by the local ethics 
committee (N 2011-0081) and conducted in accordance with the Declaration of Helsinki. All 
subjects gave written informed consent. 
 
2.2 Experimental Protocol 
The subjects participated in three sessions; each with a single infusion of buffered saline with 
one of three different pH levels (pH 5.0, 6.0 and 7.4). The infusions were conducted in 
random order and with a one-week interval between sessions. Further, 12 subjects received 
repeated infusions of either pH 5.0 or pH 7.4 solution with a one-day interval between 
infusions. In each session, neutral phosphate buffered saline (10 ml) was infused into the 
brachioradialis muscle over 20 min using a computer-controlled infusion pump.  
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Cold pain threshold (CPT), heat pain threshold (HPT), mechanical pain sensitivity 
(MPS), and pressure pain threshold (PPT) were assessed before, during, after, one hour after, 
and one day after the infusion. The pain intensity was rated by means of an electronic visual 
analogue scale (VAS). A McGill Pain Questionnaire and a pain map were completed after 
each infusion.   
 
2.3 Acidic Infusions and Pain Assessment 
The pH adjusted phosphate buffered saline (10 mL, Hospital Pharmacy of Aalborg University 
Hospital, Aalborg, Denmark) was randomly infused into the left brachioradialis muscle (2 cm 
from the superior border of cubital fossa) in a double-blinded manner with respect to the pH 
level. The infusion site was cleaned with alcohol and dried prior to the needle insertion. The 
needle (27 G, 19 mm, BD Microlance 3, Becton Dickinson, Ireland) was inserted into middle 
part of the brachioradialis muscle with a depth of 15 mm. The inserted needle was fixed to 
the skin using surgical tape and sterile cotton. A tube (200 cm, 1.5 ml, G30303M, Care 
Fusion, Switzerland) was connected to the needle from the syringe. The sterile buffers were 
infused at a constant rate of 30 ml/h for 20 minutes using a computer-controlled infusion 
pump (Asena CC MK-III, Alaris medical systems, USA). The needle and tube were removed 
immediately after completion of the infusion.  
The subjects rated the induced pain intensity on an electronic VAS on which "0 cm" 
indicated "no pain" and "10 cm" represented "most pain imaginable". The VAS signal was 
sampled every 2 seconds from the beginning of the infusion until the pain intensity had 
returned to zero. The maximal pain (VAS peak) and the area under the curve (VAS area) were 
calculated. After the infusion, the subjects were asked to draw the pain areas on an arm 
drawing describe the quality of the pain on the McGill Pain Questionnaire (MPQ).  
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2.4 Assessment Sites 
Two sites in the infusion side and two sites in the contralateral side were assessed (Fig. 1). 
CPT, HPT MPT, and PPT were assessed 1 cm from the infusion site (T2). All sensory 
assessments were also conducted at the infusion site (T1) at the same time points except 
during infusion. Further, the assessments were performed on the contralateral arm at the 
corresponding sites as controls (C2 and C1).  
 
2.5 Cutaneous Thermal Pain Sensitivity  
Cold pain threshold (CPT) and heat pain threshold (HPT) were measured (TSA 2001 II 
(CHEPS, Medoc, Israel) at T1 and C1 sites. The contact area of the thermode was 9 cm
2
. The 
baseline temperature was 32 C° (centre of neutral range). The method of limits was used by 
applying ramp stimuli at a velocity of 1 C°/s. The cut-off temperatures were 0 C° and 55 C°. 
The volunteers were asked to press a button when the respective thermal sensations were 
perceived. The mean threshold temperature of three consecutive measurements was 
calculated.  
 
2.6 Cutaneous Mechanical Pain Sensitivity  
The cutaneous sensitivity was assessed using weight-calibrated pins (128 mN, custom made 
Aalborg University) at all assessment sites. The subjects rated the cutaneous mechanical pain 
sensitivity (MPS) on a 0-5-10 Numeric Rating Scale (NRS) on which "0" represented “no 
sensation", "5" represented "pain threshold", and "10" presented "worst pain imaginable". 
The mean of the three measurements was used in the statistical analysis. 
 
2.7 Pressure Pain Sensitivity 
A hand-held pressure algometer (Somedic AB, Sweden) was used to assess the PPTs. The 
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pressure was applied to all assessment sites at a constant rate of 30 kPa/s through a 1 cm
2
 
probe. The subjects were instructed to push a button immediately when they felt the pressure 
turning into pain. The PPTs were measured twice at each site. The interval between the two 
PPT trials was at least 40 sec and the mean of the two measurements was used in the 
statistical analysis. 
 
2.9 Statistics 
The normal distribution was checked for all data. The necessary logarithmic transformation 
was performed 
18
. QST data were then analysed using a 3-way repeated measure analysis of 
variance (ANOVA) with gender as between-subject factor and testing site (T1, T2, C1, C2), 
pH levels (pH 5.0, 6.0, 7.4) and time (baseline, during, after, one hour after, and one day 
after) as within-subject factors. The VAS scores and pain areas of the different pH levels and 
of the single and repeated infusions were analysed by 2-way (pH level and gender) repeated 
measure of ANOVA. A Bonferroni test was employed for post-hoc comparisons in case of 
significant ANOVAs. All statistical calculations were performed using the Statistical Package 
for Social Sciences version 20 (SPSS, IBM). The significance level was set at P<0.05. The 
data are presented as mean and standard error of the mean (SEM).  
 
3. Results 
3.1 Acidic-evoked Pain  
The VAS profiles of the three infusions with different pH levels are shown in Fig. 2A. 
Significant differences were detected in VAS peak (ANOVA: P < 0.023, Fig. 2B) and VAS 
area (ANOVA: P < 0.012, Fig. 2C). The infusion of the pH 5.0 solution caused higher VAS 
scores (Peak 4.65) than the pH 6.0 solution (Peak 3.37) (P= 0.015) and the 7.4 solution (1.68) 
(P = 0.001). In addition, the pH 7.4 solution caused the lowest VAS scores compared with the 
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pH 6.0 solution (P= 0.016).  
The pain areas following the three different solutions are illustrated in Fig. 3. Infusion 
of the pH 5.0 solution evoked a larger area than infusion of pH 6.0 (P =0.036) and 7.4 (P 
=0.004), whereas the pH 7.4 solution evoked the smallest area compared with pH 6.0 and pH 
5.0 solution (P< 0.021).  
No gender differences were detected in VAS peak, VAS area, or drawing areas (P > 
0.092). 
 
3.2 Cutaneous Thermal and Mechanical Pain Sensitivity  
The ANOVA of the CPT, HPT, or MPS among the different solutions at any of the tested sites 
were not significant (ANOVA: P > 0.073). Likewise, no significant change was detected 
before, during, immediately after, one hour after, and one day after the infusion (ANOVA: P 
> 0.103,) or between gender (ANOVA: P > 0.087, data not presented).     
 
3.3 Pressure Pain Sensitivity  
The ANOVA demonstrated that the PPTs were different over time (ANOVA: P < 0.017) but 
not between solutions pH levels (P > 0.092). Compared with baseline, relative PPTs 
decreased immediately after, 1 hour after, and 1 day after the infusion at T1 (p<0.017) and 
during infusion at the T2 site (p<0.030) (Fig. 4AB). No significant difference was detected in 
the contralateral sites (ANOVA: P > 0.105; Fig. 4CD) and no gender difference was found 
(ANOVA: P > 0.087).   
 
3.4 Repeated Infusions 
Eight out of 12 subjects received repeated infusion of pH 5.0 solution, and 4 of them received 
repeated infusion of pH 7.4 solution No significant difference in VAS scores was detected 
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between the two repeated sessions for neither pH 5.0 nor pH 7.4 (P > 0.195) (Fig. 5A). No 
difference was detected in CPT, HPT, MPS or PPT between the two repeated sessions for 
either pH 5.0 or pH 7.4 (ANOVA: P > 0.106, data not presented). Normalized PPT values 
after the 1
st
 and 2
nd
 infusion of pH 5.0 is shown in Fig. 5B. 
 
4. Discussion 
The intensity of the acid-induced muscle pain was pH dependent whereas the deep tissue 
pressure hyperalgesia was not pH dependent. Repeated acid stimulation did not induce more 
pain or prolonged pressure hyperalgesia as compared with a single injection. No gender 
differences were found. 
 
4.1 Acid-induced Muscle Pain  
In the present study, the single infusions of the pH solution into the human forearm muscle 
produced significantly higher pain intensities than the neutral buffer (pH 7.4) and the pH 6.0 
buffer infusions, which is consistent with previous studies on acidic muscle pain models 
13, 19,
. 
The study is the first to use infusion of buffered saline with different pH levels into the same 
group of human muscles. The results provide clear evidence that the acid-evoked pain was 
pH dependent. The thin myelinated Group III and unmyelinated Group IV nerve fibres in 
muscle are responsible for transmitting muscular nociceptive information and their endings 
are sensitive to inflammatory mediators including low pH stimulation 20, 21. The decrease in 
tissue pH following muscle ischemia is believed to activate ASICs in muscle nociceptors, 
thus contributing to e.g. ischaemic muscle pain 
8, 19, 22, 23
. Clinically it is known that local 
anaesthetics with pH levels as low as 5 occasionally produce transient pain upon injection 
24, 
25
. Thus acidic infusion could be used as a muscle pain model in both animal and human 
studies.  
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4.2 Factors affecting the pain evoked by acid infusions 
Factors such as infusion volume and muscle size could affect acid-evoked pain intensity. In 
the present study, a total of 10 ml of buffered acid saline was infused into the brachioradialis 
muscle at a rate of 30ml/h. The average peak pain intensity of the evoked pain was 4.65 cm 
for the pH 5.0, 3.37 cm for the pH 6.0, and 1.68 pH 7.4 solution (Fig. 2). In previous animal 
and human studies, different volumes were used to induce pain. In studies examining male 
rats, acidic saline was injected in volumes of 20 µL into the rat masseter 
26 
and rat 
gastrocnemius muscle 
8,
 which successfully evoked pain and hyperalgesia. However, in 
human studies with injection of 0.5 ml unbuffered acid saline, approximately 3% of the total 
volume of the human masseter muscle which was comparable to the relative injection volume 
used in the rats, no significant pain was induced when compared with neutral saline injections 
12
. Infusion of five times the volume (2.5 mL) of unbuffered acidic saline into the masseter 
muscle of human subjects induced pain levels similar to the results of single injection (0.5 ml) 
in previous study 
27
.  Thus, the results of the previous human studies did not provide 
evidence that the injection/infusion volume had a major impact on the acid-induced pain 
intensity. It seems other factors, such as infusion rate, and using buffered saline may play 
more important role in the acid-evoked pain intensity. However, the injection or infusion 
volume should be considered according to the muscle volume when using an acid infusion as 
pain model. 
The infusion rate may play an important role in the acid-evoked pain. A previous study 
on acid-induced human skin pain indicated that raising the infusion rate leads to increasing 
pain by lowering the local pH more effectively and by increasing the tissue volume in which 
the proton concentration exceeds the threshold to excite nociceptors 
28
. Infusion of isotonic 
pH 5.2 phosphate buffer into the flexor carpi radialis muscle produced pain correlated with 
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the flow rate of the infusion 
19
. In a recent human study, acid saline (pH 3.3) was infused into 
the masseter muscle with a slow infusion rate of 15ml/h. The infusion evoked only mild pain 
and no mechanical allodynia or increased release of algesic substances assessed by 
microdialysis were detected 
27
. In our previous study, acid saline (pH 5.2) was infused into 
the anterior tibialis muscle and the pain level was higher and PPTs were lower following an 
infusion rate of 40 mL/h compared to the infusion rate of 20 ml/h 
13
. In the present study, the 
infusion rate of 30 mL/h was selected since the expected pain intensity was evoked by both 
pH 5.0 and pH 6.0 buffered saline during the pilot experiments when the different infusion 
rates of 10ml, 20 ml, 30ml, and 40 ml were tested. 
In addition, using buffered saline instead of unbuffered saline might be the necessary to 
evoke pain. Previous human studies have suggested that acid-induced muscle pain may be 
more effectively produced by infusion of low pH (~5) phosphate buffers 
13, 28
 than by 
injections of unbuffered acidic saline 
12, 27
. Recent human studies did not evoke the expected 
pain by means of unbuffered acid saline with pH 3.3 
12, 27
. This difference is possibly due to 
the ability of the muscle tissue to rapidly buffer pH changes after injections of acidic 
solutions. Compared with a buffered saline solution, an unbuffered saline solution could 
physiologically regain pH level more quickly because of the buffering capacity of the muscle 
tissue. Since ACIC3 channels generate sustained currents as long as the pH is acidic 
29
, the 
longer the pH in the muscle remains acidic and the longer the ASIC3 channels will be 
activated.  
 
4.3 Mechanical Hyperalgesia 
In the present healthy human study, PPT values at the infusion site (T1) and around the 
infused site (T2) were significantly decreased during the acidic infusion compared with 
baseline. However, no mechanical hyperalgesia was observed in the contralateral side 
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indicating that the acidic infusion caused local sensitisation without central mechanisms 
being involved. Further, no significant difference was detected in the three different pH 
solutions indicating that the local mechanical hyperalgesia was not pH-dependent but most 
likely a volume effect. Similar mechanical hyperalgesia was observed in the experimental 
muscle pain model conducted by injecting acidic buffer into the anterior tibialis muscle 
13
. In 
contrast, in a recent human study acid-infusion into the masseter muscle did not evoke 
mechanical hyperalgesia in either the local or contralateral side 
27
. It seems that only localised 
pain and short period local hyperalgesia were observed after infusion of acidic buffer in 
human studies. 
 
4.4 Gender Differences 
No sex-related differences in pain intensity, pain areas, or induced local pressure hyperalgesia 
were observed among the three different infusions in the present study. A previous study of 
intramuscular acidic stimulation reported that women experienced higher referred pain and 
exhibited a stronger correlation between local and referred pain than men 
13
. In rats, 
expression of ASIC3 receptors is greater in masseter muscle sensory afferent fibers in females 
compared with males 
30
.  It is unclear if a similar difference in ASIC channel expression 
occurs in humans or if the expression of ASIC channels by sensory afferent fibers varies 
depending on the muscle assessed. The present study only included a relatively small study 
sample. The non-significant findings may have resulted from inadequate statistical power. 
Future studies in humans may help to address whether there indeed sex-related differences in 
acid induced muscle pain.   
  
4.5 Effect of Repeated Acid Infusions 
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In animal studies, repeated intramuscular injections of acidic saline produced a prolonged 
bilateral mechanical hyperalgesia lasting up to 30 days 
11
 providing the first insight into the 
molecular mechanisms underlying the development of chronic muscle hyperalgesia 
8
. 
However, in the present human study, contralateral spreading of pain and hyperalgesia was 
not observed following repeated infusions of acidic saline. In line, repeated infusion of 
unbuffered acidic saline into human masseter muscle did not evoke any mechanical 
hyperalgesia in either the local or the contralateral side 
12, 27
. Repeated infusions into the 
tibialis muscle induced short-lasting (20 minutes) local hyperalgesia without involving the 
contralateral side 
13
. It is not clear why the repeated acidic infusion in humans did not 
reproduce any long-lasting and widespread hyperalgesia similar to those in animals. It should 
be noted that conflicting results were also found in a previous animal study where the 
mechanical allodynia could not be detected after two repeated injections of acidic saline into 
the masseter muscle 
17
. The modality differences between acidic saline, buffered or 
unbuffered, flow rate, infusion volume, intervals between repeated infusions, different 
muscles, trigeminal region vs spinal region, and evoked pain intensity are likely to contribute 
to the controversial results. Another explanation might be the difference in the total amount 
of acid stimulation between the animal and human studies as a larger part of the muscle was 
actually stimulated in the animals; whereas only a small part of the muscle was affected in 
humans.  Again, the relatively smaller sample size may also contribute to the negative 
result.  
 
5.  Conclusions 
Infusions into the brachioradialis muscle induced pain that was pH-dependent and 
mechanical hyperalgesia that was pH independent. However, repeated intramuscular acidic 
saline injection model of prolonged hyperalgesia in rodents could not be translated into a 
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human for modelling chronic musculoskeletal pain.  
 
6. Implications 
The acid-induced pain model may reflect the early stage responses to tissue injury of clinical 
conditions. It was not possible to use this human intramuscular acidic saline infusion model 
to produce the type of prolonged local and widespread hyperalgesia that has previously been 
demonstrated to occur in animal models.  
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Figure legends 
Fig. 1. Infusion Sites and Testing Sites  
T1: infusion site on the left brachioradialis muscle; T2: local testing site, 1 cm from infusion 
site. C1 and C2: testing sites on the contralateral brachioradialis muscle   
 
Fig. 2. Visual Analogue Scale (VAS) Profile and Pain Area Under the Curve 
Mean VAS scores after pH 5.0 (blue), pH 6.0 (red), or pH 7.4 (green) infusion of acidic 
buffered saline into the left brachioradialis muscle in healthy humans (Mean ± Standard Error, 
N=20). * indicates significant difference (P < 0.05).   
 
Fig. 3. Pain Drawing Area 
The pain distribution after pH 5.0, pH 6.0, or pH 7.4 infusion of acidic buffered saline into 
the left brachioradialis muscle in healthy humans (N=20). Blue and red lines represent men 
and women, respectively. 
 
Fig. 4. Pressure Pain Threshold 
Mean (± standard error of the mean, N=20) pressure pain thresholds relative (%) to baseline 
measures on the infused site T1 (A), local site T2 (B) and contralateral side C1 (C), C2 (D) 
by the infusion of pH 5.0 (blue), pH 6.0 (red), or pH 7.4 (green) buffered saline into the left 
brachioradialis muscle in healthy humans. * indicates significant difference (P < 0.05) 
compared with baseline. 
 
Fig. 5. VAS scores and PPT Changes after Repeated Infusion 
A: Mean VAS scores of the first (blue solid line) and second (blue dotted line) infusion of pH 
5.0 acidic saline (N=8) and the first (green solid line) and second (green dotted line) infusion 
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of pH 7.4 neutral phosphate buffered saline (N=4) into the left brachioradialis muscle in 
healthy humans (N=12). B: Means of % changes (relative changes to the baseline of the 
respective days) of pressure pain threshold from the baseline at the T2 testing site after the 
first (blue) and second (black) infusion of pH 5.0 acidic saline into the left brachioradialis 
muscle in healthy humans. The relative changes of PPTs were significantly lower during 
infusion of pH 5.0 acidic saline, but no significant difference was detected between two 
repeated sessions. 
